Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up

Table 4 Number of major adverse cardiovascular events in 205 patients stratified by a 2-hour OGTT

	NGT	IFG/IGT	New T2DM	Known T2DM	P
MACE^a, n (%)	35 (41)	23 (33)	18 (47)	4 (33)	NS
All-cause mortality, n (%)	18 (21)	13 (19)	12 (32)	3 (25)	NS
Cardiac revascularisation (NSTEMI/STEMI/SA/CABG), n (%)	11 (13)	10 (14)	5 (13)	3 (25)	NS
Stroke (ischemic/hemorrhagic), n (%)	6 (7)	1 (1)	2 (5)	0 (0)	NS

MACE major adverse cardiovascular events, OGTT oral glucose tolerance test, NGT normal glucose tolerance, IFG/IGT impaired fasting glucose/impaired glucose tolerance, New T2DM newly detected type 2 diabetes mellitus, Known T2DM known type 2 diabetes mellitus, NSTEMI non-ST-segment elevation myocardial infarction, STEMI ST-segment elevation myocardial infarction, SA stable angina, CABG coronary bypass graft, NS not significant
^aPatients with multiple cardiovascular events were only accounted for their first MACE

ISSN: 1471-2261